Improving the detection of carbapenemase-producing organisms (CPO) in a low-prevalence setting: evaluation of four commercial methods and implementation of an algorithm of testing-Reference-Cited by-同舟云学术

Improving the detection of carbapenemase-producing organisms (CPO) in a low-prevalence setting: evaluation of four commercial methods and implementation of an algorithm of testing

Published:2018-02-01 Issue:2 Volume:67 Page:208-214
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Vanstone G. L.¹,Woodhead S.¹,Roulston K.²,Sharma H.²,Wey E.²,Smith E. R.²,Mack D.²,Balakrishnan I.²

Affiliation:

1. HSL Analytics LLP, 1 Mabledon Place, London WC1H 9AJ, UK

2. The Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference15 articles.

1. Carbapenemases: molecular diversity and clinical consequences

2. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan

3. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae : an economic evaluation from a hospital perspective

4. Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance

5. European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries;Glasner;Euro Surveill,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistome-based surveillance identifies ESKAPE pathogens as the predominant gram-negative organisms circulating in veterinary hospitals;Frontiers in Microbiology;2023-09-07

2. Accuracy of Xpert Carba-R Assay for the Diagnosis of Carbapenemase-Producing Organisms from Rectal Swabs and Clinical Isolates;The Journal of Molecular Diagnostics;2021-11

3. Vitek® 2 MICs as first-line phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa;Future Microbiology;2021-07

4. Recent advances in rapid antimicrobial susceptibility testing systems;Expert Review of Molecular Diagnostics;2021-05-20

5. Análisis del valor predictivo de los criterios de aislamiento preventivo en una unidad de cuidados intensivos;Medicina Intensiva;2021-05